Desmopressin in the treatment of daytime urinary frequency in patients with multiple sclerosis

Journal of Neurology Neurosurgery and Psychiatry

Volumn 65, Issue 5, 1998, Pages 778-780

  Hoverd, Patricia A ^a   Fowler, Clare J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Bladder dysfunction; Desmopressin; Multiple sclerosis; Urinary frequency

Indexed keywords

DESMOPRESSIN; SODIUM;

ADULT; AGED; ARTICLE; BLADDER DYSFUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPONATREMIA; INTRANASAL DRUG ADMINISTRATION; MALE; MICTURITION; MULTIPLE SCLEROSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; SODIUM BLOOD LEVEL;

EID: 0031734756     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.65.5.778     Document Type: Article

References (6)

1. Hilton P, Hertogs K, Stanton S. The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis. J Neurol Neurosurg Psychiatry 1983;46:854-5.
2. Eckford S, Swami K, Jackson S, et al. Desmopressin in the treatment of nocturia and enuresis in patients with multiple sclerosis. Br J Urol 1994;74:733-5.
3. Valiquette G, Herbert J, Meade-D'Alisera P. Desmopressin in the management of nocturia in patients with multiple sclerosis. Arch Neurol 1996;53:1270-5.
4. Fredrikson S. Nasal spray desmopressin treatment of bladder dysfunction in patients with multiple sclerosis. Acta Neuro Scand 1996;94:31-4.
5. Kinn A-C, Larsson P. Desmopressin: a new principle for symptomatic treatment of urgency and incontinence in patients with multiple sclerosis. Scand J Urol Nephrol 1990; 24:109-12.
6. Fowler CJ, van Kerrebroeck PEV, Nordenbo A, et al. Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 1992;55: 986-9.